3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cellsCHIBA, Tetsuhiro; SUZUKI, Eiichiro; IWAMA, Atsushi et al.International journal of cancer (Print). 2012, Vol 130, Num 11, pp 2557-2567, issn 0020-7136, 11 p.Article

Screening for improved activity of a transglutaminase from Streptomyces mobaraensis created by a novel rational mutagenesis and random mutagenesisYOKOYAMA, Keiichi; UTSUMI, Hiroe; NAKAMURA, Takefumi et al.Applied microbiology and biotechnology. 2010, Vol 87, Num 6, pp 2087-2096, issn 0175-7598, 10 p.Article

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerMORIZANE, Chigusa; OKUSAKA, Takuji; FURUSE, Junji et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 2, pp 313-319, issn 0344-5704, 7 p.Article

A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinomaOGASAWARA, Sadahisa; CHIBA, Tetsuhiro; OOKA, Yoshihiko et al.Investigational new drugs. 2014, Vol 32, Num 4, pp 762-768, issn 0167-6997, 7 p.Article

Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaFURUSE, Junji; ISHII, Hiroshi; NAKACHI, Kohei et al.Cancer science. 2008, Vol 99, Num 1, pp 159-165, issn 1347-9032, 7 p.Article

Solid-Liquid Equilibria in an L-Isoleucine + L-Norleucine + Water SystemKAMEI, Toshimichi; HASEGAWA, Kazuhiro; KASHIWAGI, Tatsuki et al.Journal of chemical and engineering data (Print). 2008, Vol 53, Num 6, pp 1338-1341, issn 0021-9568, 4 p.Article

A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinomaOOKA, Yoshihiko; CHIBA, Tetsuhiro; OGASAWARA, Sadahisa et al.Investigational new drugs. 2014, Vol 32, Num 4, pp 723-728, issn 0167-6997, 6 p.Article

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancerSUZUKI, Eiichiro; IKEDA, Masafumi; OKUSAKA, Takuji et al.Cancer chemotherapy and pharmacology. 2013, Vol 71, Num 5, pp 1141-1146, issn 0344-5704, 6 p.Article

Solid-Liquid Equilibria in an L-Isoleucine + L-Alanine + Water SystemKAMEI, Toshimichi; HASEGAWA, Kazuhiro; KASHIWAGI, Tatsuki et al.Journal of chemical and engineering data (Print). 2008, Vol 53, Num 12, pp 2801-2806, issn 0021-9568, 6 p.Article

Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patientsMORIZANE, Chigusa; OKUSAKA, Takuji; SUZUKI, Eiichiro et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 957-964, issn 0344-5704, 8 p.Article

Incorporation of ¹⁵N-Labeled Ammonia into Glutamine Amide Groups by Protein-Glutaminase and Analysis of the Reactivity for α-LactalbuminMIWA, Noriko; SHIMBA, Nobuhisa; NAKAMURA, Mina et al.Journal of agricultural and food chemistry (Print). 2011, Vol 59, Num 24, pp 12752-12760, issn 0021-8561, 9 p.Article

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 CasesSUZUKI, Eiichiro; FURUSE, Junji; KOJIMA, Yasushi et al.Oncology. 2010, Vol 79, Num 1-2, pp 39-45, issn 0030-2414, 7 p.Article